但从2024年下半年开始，她发现问诊平台的单量开始平稳下滑，"当时我们都不知道原因，后来接触AI 多了，大家才意识到，很多浅层的，和医疗健康相关的咨询已经开始被AI替代了。" "所有常规标准化的问诊，都会逐步被AI取代。"长期从事互联网医疗相关工作的资深人士徐晓向《健闻 咨询》表示，在他看来，这部分可被替代的问诊需求，在所有线上问诊场景里的占比接近80%。 做了近10年的线上问诊，舒浩没有想到，变化会来得如此之快。 舒浩是国内某头部三甲医院的一名内科高年资主治，从2016年开始接触线上问诊，几家主流的在线问诊 平台他都注册了个遍。从单量上来看，他在几个核心平台都算是靠前的，一个月平均能接500单左右。 今年10月下旬，他所服务的某个主力平台发布了一款AI健康管家类产品。当时，这个偏行业侧的消息 并没有引起他的重视。直到11月过半，他发现自己在该平台上的线上问诊量缩水了40%左右。 "其它平台的问诊量之前也有一些下降，大概在20%左右。"舒浩说。 在某互联网医疗公司任职的苏玉更早捕捉到了这种趋势，她所在的公司很早就围绕线上问诊做了独立的 业务布局，医生黏性强，在用户端的口碑也很好。 巧合的是，最近互联网医疗行业 ...

Core Viewpoint - JD Health and Wuhan University People's Hospital have signed a cooperation agreement to explore a new model of "medical + technology + service" integration, aiming to enhance the accessibility and experience of public health services [1][3]. Group 1: Home Testing Service - The collaboration will launch a "home testing" service in Hubei, creating a medical testing service circle covering 10-15 kilometers around Wuhan University People's Hospital [3]. - Patients, especially elderly individuals with chronic diseases, can order blood sample collection online, with results available within three hours, followed by online expert consultation [3]. Group 2: Telemedicine Center - JD Health and Wuhan University People's Hospital will jointly establish a telemedicine center to extend the hospital's expert resources nationwide, particularly benefiting patients in areas with limited medical resources [3][4]. - The partnership aims to create a closed-loop online healthcare service that includes medical consultation, testing, diagnosis, and medication [3]. Group 3: Health Education Initiatives - The two organizations will collaborate on health education projects, utilizing expert live streams, short videos, and articles to make medical knowledge more accessible to the public [3][4]. - This initiative is part of a broader effort to improve public health literacy [3]. Group 4: Future Collaboration Plans - Future plans include exploring remote surgical guidance, imaging diagnosis, specialized disease management, and post-diagnosis follow-up, aiming to create an integrated online and offline service experience [4]. - The partnership reflects JD Health's commitment to enhancing the healthcare industry through digital technology and social services, contributing to the "Healthy China 2030" strategy [4].

叮当健康(09886)发布公告，于2025年12月8日，该公司斥资61.7万港元回购58.3万股股份，每股回购价 1.03-1.07港元。 ...

本报讯(记者袁传玺)12月6日，第二届中国呼吸健康大会在广东越秀国际会议中心举行。京东健康受邀 参会，并正式成为"中医药呼吸健康发展共同体"成员。作为本次大会的重要亮点之一，京东健康在现场 正式启动"呼吸健康万医行"线上公益科普与培训活动。 该活动以"医生培训全覆盖、科普知识广传播"为核心目标，依托医疗服务平台的专业优势，京东健康与 香雪制药、特一药业（002728）、葛兰素史克、欧彼乐、华盖制药等多家知名药企及品牌达成深度合 作，共同构建了融合医生专业培训与患者健康科普的线上公益服务体系。 据介绍，"呼吸健康万医行"活动将重点开展两大核心板块工作。面对医生，依托"院士大查房"等成熟培 训经验，此次活动将围绕呼吸疾病诊疗规范、早诊早治技术、中西医结合要点等关键内容，经权威专家 审核打磨形成专业课程体系，并通过京东医生APP、南山呼吸等平台，以文章、视频、直播等多元化形 式进行培训。 在患者科普方面，行动将组织呼吸疾病领域专家团队开展线上健康科普，聚焦呼吸道疾病预防、吸烟危 害、雾霾天防护、慢性病长期管理等公众关注热点，用通俗易懂的语言传递专业知识。同步开设的远程 义诊通道，将通过京东APP、京东健康APP为公 ...

里昂发布研报称，京东健康(06618) 与阿里健康(00241)今年第三季度业绩强劲，并鉴于以旧换新政策的 基数效应，认为这两间公司第四季度业绩指引较为保守，但他们对明年的药品销售增长及利润率扩张均 持正面展望。里昂预测两家公司明年收入将实现双位数增长，其中京东健康增速更快; 并将阿里健康目 标价从6.5港元下调至6港元，以反映第三方商品交易总额及营收增长预期放缓;而京东健康目标价则为 71港元;两间公司均维持"跑赢大市"评级。 里昂预计，上述两家公司原研药销售从医院内渠道转向医院外渠道，以及药企营销预算向线上转移的趋 势预计将持续数年。里昂又预计，两间公司下季度的营收年增率均在15%左右;并预计在原研药销售持 续增长的支撑下，京东健康2026财年营收将实现接近20%的同比增长，阿里健康2027财年营收将实现接 低十位数(low teens)的同比增长。然而，由于以旧换新基数较高，医疗器械销售可能会放缓，阿里健康 在营养品、第三方商品交易总额(GMV)和营收方面可能面临更大的压力;两家公司的长期调整后净利润 率约为13%。 ...

里昂发布研报称，京东健康（06618） 与阿里健康（00241）今年第三季度业绩强劲，并鉴于以旧换新政策的基数效应，认为这两间公司第四 季度业绩指引较为保守，但他们对明年的药品销售增长及利润率扩张均持正面展望。里昂预测两家公司 明年收入将实现双位数增长，其中京东健康增速更快； 并将阿里健康目标价从6.5港元下调至6港元，以反映第三方商品交易总额及营收增长预期放缓；而京东 健康目标价则为71港元；两间公司均维持"跑赢大市"评级。 里昂预计，上述两家公司原研药销售从医院内渠道转向医院外渠道，以及药企营销预算向线上转移的趋 势预计将持续数年。里昂又预计，两间公司下季度的营收年增率均在15%左右；并预计在原研药销售持 续增长的支撑下，京东健康2026财年营收将实现接近20%的同比增长，阿里健康2027财年营收将实现接 低十位数（low teens）的同比增长。然而，由于以旧换新基数较高，医疗器械销售可能会放缓，阿里健康在营养品、 第三方商品交易总额（GMV）和营收方面可能面临更大的压力；两家公司的长期调整后净利润率约为 13%。 热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易 客户端 里昂发布研报称，京东健 ...

从资金流向上来看，当日互联网医疗板块主力资金净流出12.28亿元，游资资金净流入1.6亿元，散户资金 净流入10.67亿元。互联网医疗板块个股资金流向见下表： 证券之星消息，12月8日互联网医疗板块较上一交易日上涨0.57%，荣科科技领涨。当日上证指数报收于 3924.08，上涨0.54%。深证成指报收于13329.99，上涨1.39%。互联网医疗板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 301017 | 漱玉平民 | 14.90 | -1.91% | 22.78万 | 3.39 Z | | 000705 | 浙江震元 | 9.91 | -1.49% | 8.64万 | 8588.10万 | | 600572 | 康恩贝 | 4.65 | -1.48% | 33.46万 | 1.56亿 | | 300937 | 药易购 | 34.44 | -1.46% | 8.47万 | 2.93亿 | | 000725 | 京东方 A | 4.21 | -1.17% | 1189. ...

Group 1 - The core viewpoint is that Ping An Good Doctor is leveraging technology to create a unique value growth curve by integrating medical, health, and elderly care services, while utilizing AI technology and deep integration with its parent company, Ping An Group [1] - The competitive advantage is rooted in its unique resource endowment, including a customer base of over 247 million individuals and more than 1.4 billion structured consultation data points, which serve as fuel for training AI models [1] - AI applications have led to a 52% reduction in service costs per family doctor client while maintaining a diagnostic accuracy rate of around 98% [1] Group 2 - Ping An Good Doctor is expanding from the C-end consumer market to B-end corporate health services, with B-end business expected to grow at a compound annual growth rate (CAGR) of 30%-50% over the next 3 to 5 years [2] - The company is focusing on high-value diagnostic services and corporate health solutions, which is expected to increase its net profit margin from an estimated 5%-6% in 2025 to over 10% [2] - The stock price of Ping An Good Doctor has more than doubled this year, reflecting investor confidence in its strategic transformation and growth prospects [2] Group 3 - The competitive advantage is not solely based on technology or traffic, but on building an ecosystem that integrates health management, insurance protection, and smart technology through a dual focus on "family doctors and elderly care" [3] - The company is transitioning from "scale expansion" to "value cultivation" in response to the accelerating trend of population aging and health consumption upgrades [3] - This transformation represents a significant leap in business model and is a vivid practice of the vision of "technology empowering a healthy China" [3]

Core Insights - Ping An Good Doctor is leveraging technology to create a unique value growth curve by integrating healthcare, insurance, and AI technology, distinguishing itself in a homogenized insurance product market [1] - The company's competitive edge lies in its extensive ecosystem resources and data accumulation, supported by over 247 million individual customers from its parent company, Ping An Group, and more than 1.4 billion structured consultation data points [1] - The application of AI has led to a 52% reduction in service costs per family doctor while maintaining a diagnostic accuracy of around 98% [1] Group 1 - The B2B segment is emerging as a new growth engine for Ping An Good Doctor, with expected compound annual growth rates (CAGR) of 30%-50% over the next 3-5 years [2] - The company is focusing on high-value medical services and corporate health solutions, which is anticipated to improve net profit margins from an estimated 5%-6% in 2025 to over 10% [2] - The stock performance of Ping An Good Doctor has been strong, with a year-to-date increase of over 100%, reflecting investor confidence in its strategic transformation and growth prospects [2] Group 2 - The competitive advantage of Ping An Good Doctor is not solely based on technology or traffic but on its dual focus of "family doctor + elderly care manager," creating an integrated ecosystem of health management, insurance protection, and smart technology [3] - The company is transitioning from "scale expansion" to "value cultivation," positioning itself strategically in the new arena of deep integration between healthcare and financial insurance amid accelerating population aging and health consumption upgrades [3] - This transformation represents not only a shift in business model but also a practical realization of the vision of "technology empowering a healthy China" [3]

12月5日，以"人工智能与医疗健康深度融合"为主题的"AI+医疗沙龙"创新论坛在上海模速空间举办。恰逢乌镇互联网医院成立十周年，该论坛聚焦医疗健康 产业与人工智能技术深度融合的行业发展方向，医疗与人工智能领域专家围绕相关议题展开深入研讨。微医医疗人工智能首席战略官、乌镇互联网医院创始 院长张群华教授出席活动并发表主旨演讲，分享了微医十年来从打造互联网医院到升级人工智能医院的实践历程。 当前，我国医疗资源分布不均、慢性病负担加重、人口老龄化趋势明显，传统医疗服务模式面临诸多挑战。在此背景下，借助人工智能技术提升医疗服务质 量和效率，成为医疗健康行业发展的重要方向。张群华在演讲中表示，互联网医疗解决了医疗服务可及性的问题，人工智能则为医疗系统赋予了"智慧大 脑"，二者的融合并非简单的技术叠加，更是对医疗资源配置方式、诊疗流程以及健康管理范式的重构。 回顾微医的发展历程，其成长轨迹也是中国"互联网+医疗健康"行业发展的一个缩影。2015年，微医创建的乌镇互联网医院正式成立，这是我国首家互联网 医院，标志着互联网与医疗领域的融合进入新阶段。该医院率先推出在线处方、在线复诊、远程会诊等创新服务模式，相关案例被写入《中国 ...